Clinical Trial: Brentuximab Vedotin and Bendamustine for the Treatment of Hodgkin Lymphoma and Anaplastic Large Cell Lymphoma (ALCL) (SGN + Benda)

Sponsor and Collaborators Owen A. O'Connor
British Columbia Cancer Agency

Princess Margaret Hospital, Canada

Contact
Molly Patterson
mp2621@columbia.edu    

Sean Clark-Garvey
sc2359@columbia.edu

Principal Investigator
Owen A O'Connor, MD, Ph.D.
Columbia University

ClinicalTrials.gov Identifier
NCT01657331

Loading links....
You must be a registered member of ONA to post a comment.

Sign Up for Free e-newsletters

Regimen and Drug Listings

GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION

Bone Cancer Regimens Drugs
Brain Cancer Regimens Drugs
Breast Cancer Regimens Drugs
Endocrine Cancer Regimens Drugs
Gastrointestinal Cancer Regimens Drugs
Genitourinary Cancer Regimens Drugs
Gynecologic Cancer Regimens Drugs
Head and Neck Cancer Regimens Drugs
Hematologic Cancer Regimens Drugs
Lung Cancer Regimens Drugs
Other Cancers Regimens
Rare Cancers Regimens
Skin Cancer Regimens Drugs